
We are transforming drug development and improving patient outcomes
Our machine learning approaches are rooted in high-quality data
Standard of care modalities
Direct access to longitudinal pathology training data collected in routine practice:
Histopathology data
- H&E
- IHC
Omics data
- DNA sequencing
- RNA sequencing
Clinical metadata
- Diagnosis, treatment, outcomes, etc.
“Future of care” modalities
Access to research cohorts and archived tissue that can be used to generate bespoke training data on demand:
DNA
- Methylomics
RNA
- scRNA-seq
- Spatial transcriptomics
Protein
- mIF
- Bulk & Spatial Proteomics

We have extensive subject-matter expertise
At Aignostics, good science is at the core of what we do, which is why we’ve built an interdisciplinary team of highly accomplished biologists, pathologists, and machine learning engineers.
In addition to our work with biopharma clients, our team frequently collaborates with external research partners on thought leadership, clinical research, and technical projects that help advance the fields of AI and pathology more broadly.

Charité – Universitätsmedizin Berlin is one of the largest university hospitals in Europe. Originally founded in 1710 as a charity hospital, the hospital has been affiliated with many influential scientists in its 300+ year history, including Rudolf Virchow, the founder of cellular pathology and namesake of our first foundation model, RudolfV. Today, Charité Berlin is regarded as one of the premiere hospitals in Europe and sees over 900,000 patients annually.

Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world. It has been ranked number one in the United States for seven consecutive years in U.S. News & World Report's Best Hospitals Honor Roll. With over 150 years of innovation, Mayo Clinic is pioneering an integrated, team-based approach to medicine, including its new focus on digital pathology.

The Ludwig Maximilian University of Munich is a leading public research university in Europe. Originally established as the University of Ingolstadt in 1472 by Duke Ludwig IX of Bavaria-Landshut, it is one of Germany's oldest continually operating universities. More recently, LMU was conferred the title of “University of Excellence” under the German Universities Excellence Initiative for its outstanding work in research and teaching.

Products and services
Products
We offer a range of rigorously developed products for precision medicine that empower your organization to generate valuable insights for drug development.
Pathology Foundation Models
Services
We offer custom services for complex image and data analysis from early drug discovery through regulated clinical applications.